Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hafkin

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Antimicrobial Agents and Chemotherapy|December 30, 2015
Efficacy and Safety of AFN-1252, the First Staphylococcus-Specific Antibacterial Agent, in the Treatment of Acute Bacterial Skin and Skin Structure Infections, Including Those in Patients with Significant ComorbiditiesB Hafkin, N Kaplan, B Murphy
Developments in Biological Standardization|January 1, 1978
Human rabies globulin and human diploid vaccine dose determinationsB Hafkin, M E Alls, G M Baer
Antimicrobial Agents and Chemotherapy|October 23, 1997
Effects of food and sucralfate on a single oral dose of 500 milligrams of levofloxacin in healthy subjectsL J Lee, B Hafkin, I D Lee, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1979
Effects of interferon and adenine arabinoside treatment of hepatitis B virus infection on cellular immune responsesB Hafkin, R B Pollard, M L Tiku, et al.
JAMA|March 19, 1982
Cholera on the Texas Gulf CoastM T Kelly, J W Peterson, H E Sarles, et al.
Journal of Clinical Pharmacology|August 1, 1997
Absence of a pharmacokinetic interaction between intravenous theophylline and orally administered levofloxacinL G Gisclon, C R Curtin, C L Fowler, et al.
The American Journal of Tropical Medicine and Hygiene|November 1, 1982
Reintroduction of dengue fever into the continental United States. I. Dengue surveillance in Texas, 1980B Hafkin, J E Kaplan, C Reed, et al.
JAMA|August 22, 1980
Clinical experience with a human diploid cell rabies vaccineL J Anderson, W G Winkler, B Hafkin, et al.
Clinical Pharmacology and Therapeutics|March 1, 1996
Safe coadministration of terbinafine and terfenadine: a placebo-controlled crossover study of pharmacokinetic and pharmacodynamic interactions in healthy volunteersB Robbins, C T Chang, J A Cramer, et al.
Neurology|April 1, 1987
Risk factors for Guillain-Barré syndromeR A Kaslow, J Z Sullivan-Bolyai, R C Holman, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|December 30, 2015
Efficacy and Safety of AFN-1252, the First Staphylococcus-Specific Antibacterial Agent, in the Treatment of Acute Bacterial Skin and Skin Structure Infections, Including Those in Patients with Significant ComorbiditiesB Hafkin, N Kaplan, B Murphy
Developments in Biological Standardization|January 1, 1978
Human rabies globulin and human diploid vaccine dose determinationsB Hafkin, M E Alls, G M Baer
Antimicrobial Agents and Chemotherapy|October 23, 1997
Effects of food and sucralfate on a single oral dose of 500 milligrams of levofloxacin in healthy subjectsL J Lee, B Hafkin, I D Lee, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1979
Effects of interferon and adenine arabinoside treatment of hepatitis B virus infection on cellular immune responsesB Hafkin, R B Pollard, M L Tiku, et al.
JAMA|March 19, 1982
Cholera on the Texas Gulf CoastM T Kelly, J W Peterson, H E Sarles, et al.
Journal of Clinical Pharmacology|August 1, 1997
Absence of a pharmacokinetic interaction between intravenous theophylline and orally administered levofloxacinL G Gisclon, C R Curtin, C L Fowler, et al.
The American Journal of Tropical Medicine and Hygiene|November 1, 1982
Reintroduction of dengue fever into the continental United States. I. Dengue surveillance in Texas, 1980B Hafkin, J E Kaplan, C Reed, et al.
JAMA|August 22, 1980
Clinical experience with a human diploid cell rabies vaccineL J Anderson, W G Winkler, B Hafkin, et al.
Clinical Pharmacology and Therapeutics|March 1, 1996
Safe coadministration of terbinafine and terfenadine: a placebo-controlled crossover study of pharmacokinetic and pharmacodynamic interactions in healthy volunteersB Robbins, C T Chang, J A Cramer, et al.
Neurology|April 1, 1987
Risk factors for Guillain-Barré syndromeR A Kaslow, J Z Sullivan-Bolyai, R C Holman, et al.
Pageof 2